Abstract
Graeme J. Hankey MD, FRCP Section Editor: Puerarin, a form of herbal medicine, is widely used in the treatment of acute ischemic stroke in China, but its efficacy is uncertain. The objective of this review was to assess the efficacy and safety of puerarin in patients with acute ischemic stroke. The primary objective was to determine whether puerarin improves functional outcome without causing undue harm in patients with acute ischemic stroke. The secondary objective was to assess the adverse events and quality of life. We searched the Cochrane Stroke Group Trials Register (last searched August 2006), the Trials Register of the Cochrane Complementary Medicine Field (last searched June 2006), and the Chinese Stroke Trials Register (last searched June …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
